N. Stübiger

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

R. Vonthein, B. Grimbacher, H. Peter, 2003, The British journal of ophthalmology.

The Challenge of Treating the Severest Forms of Chronic Noninfectious Posterior and Panuveitis

Y. Atiskova, M. Spitzer, Christoph Spartalis, 2023, Klinische Monatsblätter für Augenheilkunde.

Interferon as a treatment for uveitis associated with multiple sclerosis

A. Heiligenhaus, C. Fiehn, B. Wildemann, 2005, British Journal of Ophthalmology.

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis

M. Zierhut, I. Kötter, D. Doycheva, 2009, British Journal of Ophthalmology.

Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin.

C. Zouboulis, C. Zouboulis, I. Fresko, 2001, Tissue antigens.

with polyangiitis

C. Heinz, A. Rothova, C. Lowder, 2022 .

Morbus Behçet: Uveitis-Therapie mit Interferon α2a - prospektive klinische (Pilot-)Studie an 33 Patienten1

M. Zierhut, N. Stübiger, I. Kötter, 2001 .

HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon α

L. Kanz, R. Kandolf, M. Zierhut, 2001, Annals of the rheumatic diseases.

Uveitis in Children

A. Heiligenhaus, D. Besch, M. Zierhut, 2005, International ophthalmology clinics.